NL-OMON56905尚未招募不适用
Development and validation of an epigenetic biomarker that predicts treatment success and allows personalized management in rheumatoid arthritis and psoriasis - EPIPSORA
Amsterdam UMC0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Diagnosis of rheumatoid arthritis or psoriasis
- •- Active symptomatic disease
- •- Indication for biologic treatment with adalimumab (both), tocilizumab (RA),
- •abatacept (RA), ustekinumab (PsO) or secukinumab (PsO)
排除标准
- •- Any condition which, in the opinion of the investigator, may interfere with
- •the patient's ability to comply with study procedures
- •- Received any investigational drug or another biologic in last month
研究者
相似试验
招募中
不适用
Fecal Microbiota Transfer Therapy for AutismCTRI/2022/02/040457Providence Microbiome Research Center Private Limited
已完成
不适用
Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitislcerative ColitisJPRN-UMIN000036203Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine200
已完成
不适用
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum DisorderFetal Alcohol Spectrum DisordersNCT03494738CAMC Health System600
招募中
不适用
An epigenetic analysis and gene expression profiling on autoimmune gastritis; a multicenter cross-sectional and prospective studyautoimmune gastritisJPRN-UMIN000039528Graduate School of Medicine, The University of Tokyo, Center for Epidemiology and Preventive Medicine50
招募中
不适用
Identification and Validation of Epigenetic Biomarkers of PMDDPremenstrual Dysphoric Disorder (PMDD)Premenstrual Syndrome-PMSMenstrual CyclePMDDPremenstrual SyndromeNCT06771583Johns Hopkins University500